IDL Diagnostics

0,35 SEK

+11,46%

Mindre end 1K følgere

IDLDX

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Værdiansættelse

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for IDL Diagnostics

EV/S

Medianen 2019-2021

P/B

Medianen 2019-2025

 
2019202020212022202320242025
Aktiekurs (SEK)1,172,300,930,620,440,390,35
Aktier40,277,1233,6230,4230,4230,4230,4
Markedsværdi47,1177,2217,8142,8100,789,881,3
Enterprise value33,5135,2199,4----
EV/S75,61.609,016,6----
EV/EBITDAneg.neg.neg.----
EV/EBITneg.neg.neg.----
P/Eneg.neg.neg.neg.neg.neg.neg.
P/B0,593,151,000,640,620,740,55
P/S106,42.109,118,23,92,31,61,5
Udbytteprocent0,0 %0,0 %0,0 %0,0 %0,0 %0,0 %0,0 %
Equity ratio88,0 %93,0 %95,6 %94,4 %93,6 %90,4 %83,8 %
Gearing ratio------8,9 %